Inhibikase Therapeutics (NYSE:IKT) and Renovacor (NYSE:RCOR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation. Valuation & Earnings This table compares Inhibikase Therapeutics and Renovacor’s top-line revenue, earnings per share (EPS) […]